BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
BioCryst Pharmaceuticals Inc
Inventory
BioCryst Pharmaceuticals Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
Inventory
$29.8m
|
CAGR 3-Years
80%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Inventory
$4.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Inventory
$1.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-1%
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$8.7B
|
CAGR 3-Years
30%
|
CAGR 5-Years
24%
|
CAGR 10-Years
11%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Inventory
$813.1m
|
CAGR 3-Years
40%
|
CAGR 5-Years
43%
|
CAGR 10-Years
54%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Inventory
$2.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
41%
|
See Also
What is BioCryst Pharmaceuticals Inc's Inventory?
Inventory
29.8m
USD
Based on the financial report for Mar 31, 2024, BioCryst Pharmaceuticals Inc's Inventory amounts to 29.8m USD.
What is BioCryst Pharmaceuticals Inc's Inventory growth rate?
Inventory CAGR 5Y
118%
Over the last year, the Inventory growth was 8%. The average annual Inventory growth rates for BioCryst Pharmaceuticals Inc have been 80% over the past three years , 118% over the past five years .